Sabadell Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Sabadell Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$461K	Buy	888 +400	+82%	+$216K	0.1%	91
2023 Q1	$283K	Hold	488	–	–	0.06%	97
2022 Q4	$284K	Hold	488	–	–	0.06%	108
2022 Q3	$267K	Hold	488	–	–	0.06%	106
2022 Q2	$257K	Hold	488	–	–	0.05%	136
2022 Q1	$299K	Hold	488	–	–	0.05%	153
2021 Q4	$293K	Hold	488	–	–	0.05%	147
2021 Q3	$279K	Hold	488	–	–	0.05%	149
2021 Q2	$246K	Buy	+488	New	+$230K	0.04%	152

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sabadell Asset Management's TMO Position: Q2 2023 in Review

Sabadell Asset Management increased its Thermo Fisher Scientific (TMO) stake by 82% in Q2 2023, buying an estimated $216K and bringing the position to 888 shares worth $461K. The position accounts for 0.1% of the portfolio, ranked #91.

Sabadell Asset Management first reported a position in TMO in Q2 2021 and has held it in 9 quarters since. 2,388 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

Sabadell Asset Management held 888 shares of Thermo Fisher Scientific worth $461K as of Q2 2023.
Sabadell Asset Management bought 400 Thermo Fisher Scientific shares in Q2 2023, an estimated $216K.
Thermo Fisher Scientific made up 0.1% of Sabadell Asset Management's portfolio in Q2 2023, its #91 holding.
Sabadell Asset Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 9 quarters since.
2,388 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Sabadell Asset Management's 13F filing for Q2 2023, filed 23 Jan 2024.